MONTAGUE, P.E.I.—Canadian algae producer Solarvest Bioenergy Inc. announced it has signed agreements with a pair of European facilities for the contract production using its proprietary omega-3 process.
According to Solarvest, the undisclosed facilities in European Union (EU) member countries will implement its proprietary production process and algae strains to produce omega-3s used in food manufacturing.
High-docosahexaenoic acid (DHA) samples are already being made at one facility that will be used for formulation and testing by prospective customers in the EU and North America, the Prince Edward Island-based company said.
The second facility is already producing EU-approved organic products, and Solarvest said it will work with the company to facilitate commercial scale production using Solarvest’s process.
“Production at these facilities will coincide with the continued development of the company’s production capabilities at its P.E.I. facility, according to Solarvest.
Solarvest said it plans to sell bulk omega-3 product produced at the EU facilities to food processors, while its plant in Montague, P.E.I., will continue to develop downstream processing, finishing procedures and technologies required to produce value-added omega products.
The company’s production process is the world’s first used to make omega-3 from algae.